Voranigo Alternatives Compared
Voranigo (vorasidenib) | Bevacizumab | Gliadel (carmustine) |
|
---|
Voranigo (vorasidenib) | Bevacizumab | Gliadel (carmustine) |
|
|||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Malignant Glioma. Voranigo may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Glioblastoma Multiforme, Colorectal Cancer, Cervical Cancer, Fallopian Tube Cancer, Breast Cancer, Breast Cancer - Metastatic, Hepatocellular Carcinoma, Macular Degeneration, Malignant... View more |
Prescription only
Prescribed for Brain Tumor, Glioblastoma Multiforme, Hodgkin's Lymphoma, Malignant Glioma, Multiple Myeloma, Non-Hodgkin's Lymphoma. Gliadel may also be used for purposes not listed in this medication guide. View more |
Related suggestions Malignant Glioma
|
|||||||||||||||
More about Voranigo (vorasidenib) | More about Bevacizumab | More about Gliadel (carmustine) | ||||||||||||||||
Ratings & Reviews | ||||||||||||||||||
Be the first to share your experience with this drug. |
Bevacizumab has an average rating of 7.6 out of 10 from a total of 37 ratings on Drugs.com. 68% of reviewers reported a positive effect, while 14% reported a negative effect. |
Be the first to share your experience with this drug. |
||||||||||||||||
Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||||||||||
View all Voranigo side effects |
View all Bevacizumab side effects |
View all Gliadel side effects |
||||||||||||||||
Drug Class | ||||||||||||||||||
Generic Availability | ||||||||||||||||||
N/A |
||||||||||||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||||||||||
View all Voranigo prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Gliadel prices |
||||||||||||||||
Dosage Forms | ||||||||||||||||||
|
N/A |
|
||||||||||||||||
Brand Names | ||||||||||||||||||
N/A |
Alymsys, Avastin, Avzivi, Jobevne, Mvasi, Vegzelma, Zirabev | Other carmustine brands include: BiCNU | ||||||||||||||||
Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||||||||||
240 hours |
480 hours |
67 hours |
||||||||||||||||
CSA Schedule 1 View glossary of CSA terms | ||||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
Pregnancy Category | ||||||||||||||||||
Summary unavailable. See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
||||||||||||||||
Drug Interactions | ||||||||||||||||||
A total of 436 drugs are known to interact with Voranigo:
|
A total of 50 drugs are known to interact with Bevacizumab:
|
A total of 279 drugs are known to interact with Gliadel:
|
||||||||||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
Disease Interactions | ||||||||||||||||||
First Approval Date | ||||||||||||||||||
August 06, 2024 |
N/A |
September 23, 1996 |
||||||||||||||||
WADA Class View classifications | ||||||||||||||||||
N/A |
N/A |
N/A |
||||||||||||||||
More Information | ||||||||||||||||||
Patient Resources | ||||||||||||||||||
Professional Resources | ||||||||||||||||||
Related Treatment Guide | ||||||||||||||||||
|
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.